Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
ACLX holding history
Arcellx, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACLX overviewAll 13F holders of ACLXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −5,774,016−100.0% | Sold out | Holders |
| Q1 2026 | 5,774,016 | $663.0M | 13.5% | +50,000+0.9% | Added | Holders |
| Q4 2025 | 5,724,016 | $373.2M | 10.0% | +1,075,000+23.1% | Added | Holders |
| Q3 2025 | 4,649,016 | $381.7M | 11.3% | 00.0% | Unchanged | Holders |
| Q2 2025 | 4,649,016 | $306.1M | 13.1% | +156,984+3.5% | Added | Holders |
| Q1 2025 | 4,492,032 | $294.7M | 13.6% | +120,431+2.8% | Added | Holders |
| Q4 2024 | 4,371,601 | $335.3M | 11.7% | +371,601+9.3% | Added | Holders |
| Q3 2024 | 4,000,000 | $334.0M | 11.7% | +151,905+3.9% | Added | Holders |
| Q2 2024 | 3,848,095 | $212.4M | 8.1% | +30,000+0.8% | Added | Holders |
| Q1 2024 | 3,818,095 | $265.5M | 9.3% | +159,471+4.4% | Added | Holders |
| Q4 2023 | 3,658,624 | $203.1M | 9.5% | +705,502+23.9% | Added | Holders |
| Q3 2023 | 2,953,122 | $106.0M | 7.2% | +606,122+25.8% | Added | Holders |
| Q2 2023 | 2,347,000 | $74.2M | 6.0% | +589,221+33.5% | Added | Holders |
| Q1 2023 | 1,757,779 | $54.2M | 5.1% | +875,678+99.3% | Added | Holders |
| Q4 2022 | 882,101 | $27.3M | 3.2% | +882,101 | New | Holders |